DV
Dividend Vision

MSLE — Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc. Common Stock (MSLE)

Total return is -89.8% over the past 14 years, 700.1 points behind SPY at 610.3%. Its deepest 1-year drawdown was 57.0%.

MSLE is a single-stock equity holding in Satellos Bioscience Inc., a bioscience company. The holding does not currently offer dividend distributions or a measurable yield profile, with no stated expense ratio as this represents a direct equity position rather than a traditional fund structure. This equity position is oriented toward investors seeking exposure to the bioscience sector rather than those prioritizing dividend income.

MSLE key facts

Asset type
Stock
Asset class
Equity
Inception date
08/03/2012
Last close
$9.61
Market cap
$177,585,888
Average volume
38448.0
Beta
1.17
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.79